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Cancer Susceptibility
Ken Natsuga1,2, Sara Cipolat1,3 and Fiona M. Watt3Mice lacking three epidermal barrier proteins—envoplakin, periplakin, and involucrin (EPI-/- mice)—have a
defective cornified layer, reduced epidermal gd T cells, and increased dermal CD4þ T cells. They are also
resistant to developing skin tumors. The tumor-protective mechanism involves signaling between Rae-1
expressing keratinocytes and the natural killer group 2D receptor on immune cells, which also plays a role
in host defenses against infection. Given the emerging link between bacteria and cancer, we investigated
whether EPI-/- mice have an altered skin microbiota. The bacterial phyla were similar in wild-type and EPI-/- skin.
However, bacteria were threefold more abundant in EPI-/- skin and penetrated deeper into the epidermis. The
major epithelial defense mechanism against bacteria is production of antimicrobial proteins (AMPs). EPI-/- skin
exhibited enhanced expression of antimicrobial peptides. However, reducing the bacterial load by antibiotic
treatment or breeding mice under specific pathogen-free conditions did not reduce AMP expression or alle-
viate the abnormalities in T-cell populations. We conclude that the atopic characteristics of EPI-/- skin are a
consequence of the defective barrier rather than a response to the increased bacterial load. It is therefore
unlikely that the increase in skin microbiota contributes directly to the observed cancer resistance.
Journal of Investigative Dermatology (2016) 136, 99-106; doi:10.1038/JID.2015.383INTRODUCTION
In cells of the outermost epidermal layers, the plasma
membrane is replaced by a cornified envelope, formed by
transglutaminase-1-mediated crosslinking of proteins and
lipids (Natsuga, 2014). This insoluble structure is a key
component of the epidermal barrier that protects the body
from environmental assaults (Candi et al., 2005). Defects in
the epidermal barrier are linked to atopic dermatitis
in humans and mice (Natsuga, 2014). Mice triply deficient in
three cornified envelope precursors—envoplakin, periplakin,
and involucrin (EPI-/- mice)—have epidermal barrier defects,
a reduction in epidermal gd T cells, and an increase in
dermal CD4þ T cells (Sevilla et al., 2007).
EPI-/- mice are highly resistant to developing skin tumors
when treated with chemical carcinogens (Cipolat et al.,
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13-acetate (TPA), including upregulation of the keratinocyte
stress-associated antigen Rae-1, which binds natural killer
group 2D (NKG2D) on immune cells. NKG2D ligands are
currently being evaluated as therapeutic targets in a variety of
cancer types (Spear et al., 2013).
Rae-1eNKG2D interactions are not only implicated in
cancer (Cipolat et al., 2014; Strid et al., 2008) but also
mediate host responses to bacterial and viral infection
(Hamerman et al., 2004; Lodoen et al., 2004; Strid et al.,
2008, 2009). Given the strong evidence linking the gut
microbiota, chronic inflammation, and cancer (Shanahan
and O’Toole, 2014), we speculated that the skin micro-
biome might be altered in EPI-/- mice. Human skin is covered
by wide variety of commensal microbiota, which vary in
composition according to body site, age, and health status
(Grice and Segre, 2011). In addition, studies suggest a regu-
latory role for skin commensal bacteria in skin infection and
inflammation (Lai et al., 2009; Naik et al., 2012). We
therefore investigated whether the skin microbiome differs
between EPI-/- and wild-type (WT) mice and whether it in-
fluences keratinocyte expression of Rae-1 and antimicrobial
proteins (AMPs), natural antibiotics that are effectors of the
innate immune system (Gallo and Hooper, 2012).
RESULTS
Altered abundance and distribution of bacteria in the skin of
EPI-/- mice
To determine whether EPI-/- mice had an altered skin
microbiome, we measured the quantity and diversity of mi-
crobes on the ear skin of six EPI-/- and six WT control miceestigative Dermatology. This is an open access
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Figure 1. Characterization of skin
microbiota in EPI-/- and WT mice.
(a) qPCR of 16sRNA gene in
EPI-/- and WT ear skin. Data are
means  SEM from six mice per
group. **P < 0.01. (b and c) Microbial
diversity of EPI-/- and WT ear
skin obtained by 16s RNA gene
pyrosequencing from six mice per
group. (b) Data are presented as
means of relative abundance  SEM.
(c) Each column shows relative
abundance of the bacterial phyla in a
single mouse. There were no
statistically significant differences
between WT and EPI-/- skin
microbiota phyla.
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the 16S rRNA gene revealed that the bacterial load of EPI-/-
mice skin was significantly higher than that of control mice
(Figure 1a). However, pyrosequencing of 16S rRNA gene PCR
products showed that the composition of the bacterial flora of
EPI-/- and control skin did not differ significantly (Figure 1b
and c).
The microbiota of EPI-/- skin were visualized by whole-
mount fluorescence in situ hybridization (FISH) of the
epidermis with a universal bacterial probe. There was
punctate labeling on the surface of both EPI-/- and control
skin (Figure 2a). A FISH probe for Candida dubulinienesis
served as a negative control (Biasoli et al., 2010) (Figure 2b).
In WT epidermis, bacteria were largely confined to the cor-
nified layers, which can be distinguished in vertical sections
because the cells lack nuclei (Figure 2c). However, bacteria
in EPI-/- epidermis were also localized between keratinocytes
in the living layers, extending in some cases into the basal
layer (arrowheads, Figure 2c). Quantitation of the label
confirmed that bacteria in EPI-/- epidermis were located
significantly deeper than in control epidermis (Figure 2d; WT
vs. EPI-/- : 17.13  0.04 vs. 15.89  0.02 mm to the median
line of epidermis).
Atopic features of EPI-/- mouse skin are unaffected by skin
microbiota
To determine whether the increased bacterial load influenced
the atopic phenotype of EPI-/- mice, we used two strategies to
reduce the bacterial content of the skin. One was
to breed EPI-/- mice for multiple generations under
specific-pathogen-free (SPF) barrier conditions (flora-defi-
cient EPI-/- mice). The other was to treat them systemically for
2 weeks with the broad-spectrum antibiotic enrofloxacin, a
time frame chosen on the basis that the exaggerated atopic
response to TPA we described previously (Cipolat et al.,Journal of Investigative Dermatology (2016), Volume 1362014) is induced within 9 days. Both treatments reduced
the bacterial load of EPI-/- skin to that of WT control mice
(Figure 3a).
As previously reported (Cipolat et al., 2014; Sevilla et al.,
2007), EPI-/- mice have more dermal CD4þCD3þ lympho-
cytes than control mice (Figure 3b). This difference persisted
when EPI-/- mice were depleted of bacteria (Figure 3b). The
number of epidermal gdTCRþCD3þ lymphocytes (dendritic
epidermal T cells) is reduced in EPI-/- mice (Cipolat et al.,
2014; Sevilla et al., 2007), and again this was not affected
by reducing the number of skin bacteria, when evaluated by
expression of a pan-gdTCR marker (Figure 3c) or Vg3, a
specific marker of epidermal dendritic epidermal T cells
(Figure 3d).
Dendritic epidermal T cells are involved in the lymphoid
stress-surveillance response, in which tissue damage upre-
gulates “stress-associated” genes, including Rae-1, in kerati-
nocytes, leading to the activation of immunoreceptor
NKG2D of immune cells (Strid et al., 2009). Rae-1 expression
was increased in EPI-/- mice, as described previously (Cipolat
et al., 2014), and was not reduced by depletion of the skin
microbiota (Figure 3e).
Neutrophil infiltration, indicative of chronic inflammation,
is highly elevated in TPA-treated EPI-/- skin (Cipolat et al.,
2014). There was a slight (but not statistically significant)
increase in the level of myeloperoxidase (MPO), a marker of
neutrophil activation, in untreated EPI-/- skin (Figure 3f).
MPO activity was not, however, affected by depletion of the
skin microbiota (Figure 3f). These findings were supported by
quantitating the number of Ly6G/Gr-1 positive cells (neutro-
phils) in the dermis of WT, EPI-/-, flora-deficient EPI-/-, and
antibiotic-treated EPI-/- mice (see Supplementary Figure 1,
online).
Histologically, untreated adult dorsal skin of EPI-/-
mice showed mild hyperkeratosis (Figure 4a) and an
Figure 2. Epidermal penetration by
bacteria. (a and b) Whole-mount FISH
of ear skin using BacUni (a) or
C. dubuliniensis (b) probes (green),
with DAPI counterstain (blue). The
images are Z-stack maximum
projections of the epidermis. Scale
bars ¼ 20 mm. (c) Optical sectioning
of 3D reconstructed whole-mount
FISH (BacUni). Arrowheads show
bacterial penetration of the basal
epidermal layer. Dotted line indicates
position of basement membrane.
Scale bars ¼ 10 mm. (d) Quantitation
of location of individual BacUni
signals relative to the median
thickness (dotted line) of the
epidermis. The boxes extend from
the 25th to 75th percentiles. Whiskers
indicate minimum to maximum.
****P < 0.0001.
Figure 3. Microbiota independent inflammatory and stress response phenotypes of EPI-/- skin. (a) qPCR of 16s RNA gene in WT, EPI-/-, antibiotic-treated EPI-/-
, and flora-deficient EPI-/- ear skin samples. (b) Number of CD4þCD3þ cells per mm2 dermis. (c) Number of gdTCRþ cells per mm epidermis. (d) Number of
Vg3þ cells per mm epidermis. (e) qRT-PCR of Rae-1 in WT, EPI-/-, antibiotic-treated EPI-/-, and flora-deficient EPI-/- epidermis. (f) Quantification of MPO in WT,
EPI-/-, and flora-deficient skin lysates. Data are means  SEM from at least four (a) or three (bef) mice per group. *P < 0.05, ****P < 0.001; unless indicated no
significant differences were found (one-way ANOVA followed by Tukey’s test).
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hyperkeratosis, parakeratosis, epidermal thickening,
and spongiosis (Figure 4b and c), as reported previously
(Cipolat et al., 2014; Sevilla et al., 2007). Depletionof the skin microbiota by antibiotic treatment had no ef-
fect on these features (Figure 4aec). In addition, antibi-
otics did not reduce spleen size in EPI-/- mice
(Figure 4d).www.jidonline.org 101
Figure 4. Effect of antibiotic
treatment on skin histology. (a)
Hematoxylin and eosin-stained skin
sections of WT, EPI-/-, and antibiotic-
treated EPI-/- mice at steady state.
Arrowheads, mild hyperkeratosis.
(b) Hematoxylin and eosin-stained
sections of WT, EPI-/-, and
antibiotic-treated EPI-/- skin after
three applications of TPA. White
arrowheads, severe hyperkeratosis;
asterisks, parakeratosis; black arrows,
spongiosis. Scale bars ¼ 100 mm.
(c and d) Epidermal thickness (c) and
spleen mass (d) of WT, EPI-/-, and
antibiotic-treated EPI-/- mice. TPA was
applied three times on alternating
days on all mice (n ¼ 3 or 4 per
condition). **P < 0.01, ***P < 0.001.
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102EPI-/- mice have an increased level of epidermal AMPs,
proteases, and protease inhibitors, independent of skin
microbiota
Because bacterial load was not responsible for the skin in-
flammatory phenotype or keratinocyte-specific stress
response of EPI-/- mice, we next investigated whether the
expression of AMPs was influenced by skin bacteria. Skin
AMPs belong to several distinct protein families that
target different types of bacteria (Gallo and Hooper, 2012).
We examined expression of representatives of three of
the families by qPCR. EPI-/- epidermis had significantly
elevated levels of Camp (cathelicidin-related antimicrobial
peptide; gram-positive and -negative bacteria). Defb1,
Defb2, Defb3, and Defb6 (b-defensins; gram-positive and
-negative bacteria) and S100A9 (calprotectins; Staphylo-
coccus aureus) levels were similar to control mice
(Figure 5aef). Expression of AMP genes was not affected
by depletion of the skin microbiota (Figure 5aef). Immuno-
fluorescence labeling for b3-defensin and Camp in sections
of mouse back skin suggested that both EPI-/- and flora-
deficient EPI-/- epidermis had more abundant b3-defensin
and Camp than WT epidermis (see Supplementary Figure 2,
online).
Antibiotic treatment reduces expression of intestinal AMPs,
including Pla2g2a, Reg3b, and Reg3g (Reikvam et al., 2011).
Intriguingly, these genes were not upregulated in EPI-/- skin
and were not affected by the depletion of skin microbiota
(Figure 5gei). This suggests that the AMPs of the gut and skin
respond differently to bacterial load.
Epidermal proteases are known to process native AMPs to
their active forms (Ovaere et al., 2009), and expression of one
of the major skin serine protease inhibitors, Serpina1b, isJournal of Investigative Dermatology (2016), Volume 136increased in EPI-/- skin (Sevilla et al., 2007). In contrast to
AMPs, Serpina1b levels were affected by depletion of skin
bacteria in EPI-/- mice, showing a significant increase in
antibiotic-treated and SPF-housed animals (Figure 5j). How-
ever, when WT mice were treated with antibiotics, epidermal
Serpina1b expression was not altered (see Supplementary
Figure 3, online).
In contrast to our earlier report (Sevilla et al., 2007), total
epidermal protease activity was increased in EPI-/- mice.
However, total protease activity was not affected by bacterial
depletion (Figure 5k). Casein gel electrophoresis revealed
two predominant proteins with protease activity, which,
based on electrophoretic mobility, likely correspond to
elastase 2 and kallikrein 7 (Figure 5l). Both bands were more
abundant in EPI-/- than WT skin but were not reduced by
bacterial depletion (Figure 5l). These data indicate that, like
AMP expression, total proteases are unaffected by bacterial
load in the skin of EPI-/- mice, notwithstanding the increase
in Serpina1b levels.DISCUSSION
Our study demonstrates that the epidermal barrier defect of
EPI-/- mice results in an increased bacterial load and deeper
bacterial penetration of the epidermis. Both phenomena are
most likely attributable to the previously reported fragility of
the cornified envelope and abnormalities in the intercellular
desmosomal junctions (Sevilla et al., 2007). The increase in
bacteria does not, however, impact on the atopic phenotype of
EPI-/- skin, including inflammation, upregulation of Rae-1,
AMPs, and epidermal protease activity, and does not reflect
any major changes in skin bacterial phyla.
Figure 5. AMP expression and protease activity in EPI-/- epidermis after microbiota modulation. (aek) qRT-PCR of Camp (a) , Defb1 (b), Defb2 (c), Defb3 (d),
Defb6 (e), S100A9 (f), Pla2g2a (g), Reg3b (h), Reg3g (i), and Serpina1b (j) in WT, EPI-/-, antibiotic-treated EPI-/-, and flora-deficient EPI-/- epidermis. Data are
means  SEM from at least four mice per group. *P < 0.05, **P < 0.01, ***P < 0.001. (k) Total epidermal protease activities of WT, EPI-/-, antibiotic-
treated EPI-/-, and flora-deficient EPI-/- skin. Data are means  SEM from three to four mice per group. (l) Casein gel electrophoresis of epidermal lysates.
Each lane is lysate from a different mouse. Positions of molecular mass markers (31 kDa, 17 kDa) are shown. The two major bands of proteolytic activity
are indicated by arrowheads.
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104The only exception to these observations was Serpina1b,
which, as reported previously (Sevilla et al., 2007), was
elevated in EPI-/- skin relative to WT. Serpina1b levels were
further increased by bacterial depletion in EPI-/- but not WT
skin. Although the underlying mechanism and biological
significance of the Serpina1b findings remain to be explored,
it is worth noting that elevated expression of Serpins con-
tributes to barrier dysfunction and inflammation in allergen-
treated mouse skin (Sivaprasad et al., 2015). It would be
interesting to examine whether EPI-/- mice exhibit increased
allergic contact dermatitis, because Filaggrin-null mice,
which also have a defective barrier, display an enhanced
cutaneous response to ovalbumin sensitization (Kawasaki
et al., 2012).
Our observations indicate that the major tumor-protective
mechanism identified in EPI-/- mice, namely signaling via
Rae-1 and NKG2D, is attributable to the inherent structural
defects in the epidermal barrier and not to the increase in the
skin microbiota. This is in marked contrast to the protu-
morigenic effect of flagellated bacteria that colonize skin
wounds and signal via Toll-like receptor-5 (Hoste et al.,
2015a, 2015b).
Our study distinguishes phenotypes resulting from changes
to the epidermal barrier from microbiota-induced pheno-
types. Genetic ablation of the serine protease matripase,
which processes Filaggrin and is required for normal corni-
fied envelope assembly, results in changes in the composition
of the skin microbiota and changes in AMP levels, but
whether the two phenomena are related has not been
explored (Scharschmidt et al., 2009). The AMP b-defensin-2
is upregulated in the skin of patients with atopic dermatitis
(Asano et al., 2008; Ong et al., 2002), and S. aureus in-
fections are common in these patients (Ogawa et al., 1994).
However, the skin inflammation that is a hallmark of atopic
dermatitis and other epidermal barrier disorders, such as
congenital ichthyosis (Kabashima, 2013; Oji et al., 2010), is
not alleviated by antibiotic treatment. We propose that the
altered skin microbiome associated with atopic dermatitis is a
consequence, not a cause, of the disease.
METHODS
Mice
EPI-/- mice were generated as described previously on a mixed ge-
netic background (Sevilla et al., 2007). Genome scanning performed
by the Jackson Laboratory (Bar Harbor, ME; Cipolat et al., 2014)
established that their genetic background comprises Sv129
(40.98%  1.52%), C57Bl/6 (51.39%  1.62%), and BALB/c
(4.7%  1.24%). On that basis we selected the F2 generation of
Sv129 and C57BL/6J crosses (51.82%  3.35% Sv129; 49.92% 
1.98% C57Bl/6) as the control for all experiments, because their
genetic background was 95% identical to that of EPI-/- mice. The F2
control mice were previously used in studies of the susceptibility of
EPI-/- mice to chemical carcinogenesis (Cipolat et al., 2014).
Matched control and EPI-/- mice were housed in the same envi-
ronments and had the same diet.
For some experiments multiple generations of EPI-/- and control
mice were housed under SPF conditions. Analysis was performed on
mice that had been born in pathogen free conditions in an SPF barrier
facility. Entry into the facility required staff to change into scrubs and
protective footwear, to take an air shower, and to use handJournal of Investigative Dermatology (2016), Volume 136disinfectant. Mice, whether behind the barrier or in the conventional
facility, were kept in individually ventilated cages that were only
opened in a laminar flow cabinet and were only handled with gloved
hands. For antibiotic treatment oral enrofloxacin (5 mg/kg/day) was
given to mice kept in the conventional facility for 2 weeks.
For TPA treatment, 6 nmol (3.7 mg) of TPA (Sigma-Aldrich, Gil-
lingham, UK) in 200 ml acetone was applied to mouse dorsal skin
three times on alternating days (Cipolat et al., 2014). Skin, and in
some cases spleen, was harvested 48 hours after the last TPA treat-
ment. Epidermal thickness was assessed on hematoxylin and eosin-
stained sections of TPA-treated skin using ImageJ software (NIH,
Bethesda, MD). At least six fields were analyzed per skin section. All
experiments were performed under the terms of a UK government
Home Office project license following institutional ethical review.
Analysis of bacterial load
Extraction of skin bacterial DNA was performed as described pre-
viously (Scharschmidt et al., 2009). Briefly, 5-mm diameter skin bi-
opsies were collected from the ears of age- and sex-matched mice
using sterile instruments. DNA was extracted with the PureLink
Genome DNA Mini Kit (Life Technologies, Grand Island, NY)
following the bead-beating step using Precellys 24 (Bertin Technol-
ogies, Montigny le Bretonneux, France). 16S rRNA gene qPCR was
carried out using specific primers (Bact-8F: AGAGTTTGATCCT
GGCTCAG, Bacte338R: CTGCTGCCTCCCGTAGGAGT) with fast
SYBR Green detection (Applied Biosystems, Foster City, CA) and run
on an ABI Prism 7900HT Sequence detection system (Applied
Biosystems). Standard curves were prepared by amplifying serial
dilutions of known quantities of E. coli cells. The V1-V2 region of the
16S rRNA gene was amplified using barcoded fusion primers, and
PCR products were sequenced on a 454GS FLSGX platform (Roche,
Branford, CT). Pyrosequencing reads were uploaded into QIIME
(qiime.org/) and processed as described previously (Caporaso et al.,
2010).
Whole-mount FISH
Pieces of ear skin were collected with a sterilized 3-mm biopsy
punch. Skin samples were fixed in 1:1 acetone-to-methanol and
incubated with PNA FISH probes at 55 C. A universal bacteria probe
(BacUni; AdvanDx, Woburn, MA) and probe for C. dubuliniensis
(AdvanDx) were used. DAPI was used for nuclear staining. Images
and Z-stacks of whole-mount FISH were obtained using a TCS SP5
Tandem Scanner confocal microscope (Leica, Mannheim, Germany).
Optical sectioning and Z-stack maximum projection images of
whole-mount preparations were produced using LAS AF software
(Leica). Evaluation of bacterial location was performed on three-
dimensional reconstructed skin using Volocity software (Perkin-
Elmer, Wellesley, MA). All the BacUni DAPI signals were detected
using the software. The median epidermal line was calculated using
the localization of the center of epidermal DAPI signals. The distance
of each BacUni signal from the median epidermal line was plotted.
Positive values indicate signals above the median line, whereas
negative values correspond to signals below the median line.
Immunofluorescence
Frozen sections were fixed with 4% paraformaldehyde/phosphate-
buffered saline and stained with the following antibodies conju-
gated with Alexa 488 or FITC or Alexa 633: anti-CD3 (BD Phar-
mingen, San Diego, CA, clone 17A2), anti-CD4 (eBioscience, San
Diego, CA, clone RM4-5), anti-gd TCR (BD Pharmingen, clone
GL3), anti-Vg3 TCR (BD Pharmingen, clone 536), or anti-Ly6G/Gr-1
K Natsuga et al.
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paraffin sections were treated with citrate buffer for antigen retrieval
and incubated with anti-Camp (Abcam, Cambridge, UK) or anti-b3
defensin (Alpha Diagnostic, San Antonio, TX) followed by Alexa
488-conjugated donkey anti-rabbit antibody (Life Technologies).
DAPI or PI was used for nuclear staining. Images were acquired
using a TCS SP5 Tandem Scanner or an FV1000 confocal micro-
scope (Olympus, Tokyo, Japan). When quantifying cells that
expressed a particular marker, at least six fields were analyzed per
skin section.
MPO ELISA
For MPO quantification, an MPO ELISA kit (Hycult Biotech, Uden,
Netherlands) was used according to the manufacturer’s protocol. A
3-mm punched ear skin punch biopsy was homogenized in lysis
buffer (200 mM NaCl, 5 mM EDTA, 10 mM Tris, 10% glycerin,
1 mM phenylmethylsulfonyl fluoride) and centrifuged. The super-
natants were used for MPO ELISA. The absorbance was measured
using a Sunrise spectrophotometer (Tecan, Ma¨nnedorf, Switzerland).
Quantitative reverse transcriptase PCR
RNA was extracted from murine whole skin or from epidermis that
had been scraped from the skin after incubation in phosphate-
buffered saline for 30 seconds at 56 C in phosphate-buffered sa-
line. The RNeasy mini kit (Qiagen, West Sussex, UK) was used ac-
cording to the manufacturer’s instructions. RNA concentration was
measured using an ND-100 NanoDrop spectrophotometer (Nano-
Drop Technologies, Wilmington, DE). cDNA was synthesized using
a Superscript III First-Strand Synthesis Supermix for quantitative
reverse transcriptase PCR (qRT-PCR) kit (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions. qRT-PCR was carried
out using specific primers and fast SYBR Green and run on an ABI
Prism 7900HT Sequence detection system. All samples were
compared relative to mouse Gapdh as a housekeeping control.
The following primers were used. Rae-1: CTAGTGCCACCTGG
GAATTCA (forward), CATCATTAGCTGATCTCCAGCTCA (reverse);
Camp: CTTCAACCAGCAGTCCCTAGACA (forward), TCCAGGTC
CAGGAGACGGTA (reverse); Defb2: GCCATGAGACTCTCTGCTC
(forward), TGCAACAGGGGTTCTTCTCT (reverse); Defb3:
ATTTCTCCTGGTGCTCGTGT (forward), GGAACTCCACAACTGC
CAAT (reverse); Pla2g2a: CTGTTGCTACAAGAGCCTGG (forward),
TTTTCTTGTTCCGGGCGAAA (reverse); Reg3b: CCTTAGACCGTG
CTTTCTGTG (forward), GTCCATGATGCTCTTCAAGACA (reverse);
Reg3g: ACATCAACTGGGAGACGAATC (forward), TTTGGGAT
CTTGCTTGTGGCTA (reverse); Serpina1b: CATAGGAACGGC
TTCAAAGA (forward), TCCAGATCCATATCCCCAGA (reverse);
Gapdh: AACATCAAATGGGGTGAGGCC (forward), GTTGTCATG
GATGACCTTGGC (reverse).
Epidermal protease activity
Epidermal lysates were obtained as described previously
(Descargues et al., 2005). Briefly, epidermis was homogenized in 1
M acetic acid using Precellys 24 (Bertin Technologies). After over-
night extraction at 4 C, soluble proteins were lyophilized and
resuspended in MiliQ water (Millipore, Bedford, MA). After acetone
precipitation the BCA protein assay kit (Pierce, Rockford, IL) was
used to quantify protein concentration. The soluble fraction, 2 mg,
was monitored for protease activity using the EnzChek Protease
Assay Kit (Life Technologies), according to the manufacturer’s in-
structions; 5 mg of the soluble fraction was loaded onto NovexZymogram (casein) Gels (Life Technologies) for electrophoresis. Gels
were stained with Coomassie brilliant blue.
Statistics
Statistical analysis was performed using GraphPad Prism (GraphPad
Software, San Diego, CA). Probability values were determined with
the unpaired Student’s t-test or one-way ANOVA followed by Tukey’s
test. For analysis of bacterial depth in the skin, a nonparametric
Mann-Whitney test was performed.
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